Renin

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Japanese Ministry Of Health Approves Rasilez(R), A First-in-class Direct Renin Inhibitor (DRI), For The Treatment Of ...

Published July 9, 2009, 5:15 am, Medical News Today

RasilezĀ® (aliskiren), the first new type of high blood pressure medicine in more than a decade, has been approved for use in Japan. Rasilez directly inhibits renin9, an enzyme that triggers a process leading to high blood pressure and organ damage.

Discover News | Full Story


My Pharmiweb.com

Published July 9, 2009, 2:34 am, PharmiWeb

News and press releases from the pharmaceutical industry. Comprehensive news coverage for the pharmaceutical sector from PharmiWeb.com

Discover News | Full Story


High blood pressure medicine Rasilez gets approval in Japan

Published July 9, 2009, 12:48 am, PharmaBiz

Rasilez (aliskiren), the first new type of high blood pressure medicine in more than a decade, has been approved for use in Japan. Rasilez directly inhibits renin, an enzyme that triggers a process leading to high blood pressure and organ damage.

Discover News | Full Story


(AFX UK Focus) 2009-07-08 06:18 BRIEF-Novartis says Rasilez approved in Japan

Published July 7, 2009, 10:21 pm, Interactive Investor

ZURICH, July 8 (Reuters) - Novartis AG:

Discover News | Full Story


Silent killer steals energy

Published July 6, 2009, 9:13 pm, The Post and Courier

Afflicting an estimated 74 million Americans, high blood pressure is not only a silent killer, but a silent thief of one's energy, says Dr. Michael F. Roizen, chairman of the Wellness Institute and chief wellness officer of the Cleveland Clinic.

Discover News | Full Story


New Control System Of The Body Discovered

Published July 5, 2009, 8:25 pm, Science Daily

Researchers have ameliorated inflammation of the brain in mice caused by immune cells. A receptor they discovered on T cells in the CNS plays the key role. They showed that this bradykinin receptor 1 controls the infiltration of immune cells into the CNS. When they activated B1 in mice with encephalitis, the inflammation markedly decreased. This may unveil a new target for the treatment of ...

Discover News | Full Story


Center Receives Grant Renewal For Hypertension And Vascular Disease Studies

Published July 4, 2009, 3:08 am, Medical News Today

The Hypertension and Vascular Research Center at Wake Forest University School of Medicine has received renewal of a multi-million dollar grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to continue the development of new approaches to treat hypertension and vascular disease. The program is in its 16th year of existence at the School of Medicine.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a